About
54.17USD+0.05 +0.09%
Closed • Updated at 20:51 GMT+00:00Market Cap$5.24B
Volume969.8K
Beta0.37
RSI43.70
Xenon Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Xenon Reports Q1 2026 Financial Results and Provides Business Update
Apr 30 2026
Xenon to Report Q1 2026 Financial Results on May 7, 2026
Apr 19 2026
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
Apr 7 2026
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
Mar 12 2026
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Community Chat
Ask AI
Try asking
Translate